Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Press releases
September 30, 2021
HTL launches a new bioproduction unit HTL4
Representing an investment of more than 50 million euros, this new unit dedicated to the bioproduction of pharmaceutical-grade hyaluronic acid represents a pivotal stage in the development of HTL and the largest investment ever made in the world for a biopolymer production unit.
It will enable HTL to become the largest producer of pharmaceutical-grade hyaluronic acid in the world and accelerate its international development.
Read more below.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Press releases June 5, 2025HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
-
Press releases May 27, 2025HTL Biotechnology supports National Biomedicines manufacturing Day
HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.
-
Articles April 2, 2025François Fournier Featured in Korean Press
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.